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SUMMARY
Despite the known causality of copy-number variations (CNVs) to human neurodevelopmental disorders, the mechanisms behind each gene's contribution to the constellation of neural phenotypes remain elusive. Here, we investigated the 7q11.23 CNV, whose hemideletion causes Williams syndrome (WS), and uncovered that mitochondrial dysfunction participates in WS pathogenesis. Dysfunction is facilitated in part by the 7q11.23 protein DNAJC30, which interacts with mitochondrial ATP-synthase machinery. Removal of Dnajc30 in mice resulted in hypofunctional mitochondria, diminished morphological features of neocortical pyramidal neurons, and altered behaviors reminiscent of WS. The mitochondrial features are consistent with our observations of decreased integrity of oxidative phosphorylation supercomplexes and ATP-synthase dimers in WS. Thus, we identify DNAJC30 as an auxiliary component of ATP-synthase machinery and reveal mitochondrial maladies as underlying certain defects in brain development and function associated with WS.
INTRODUCTION
Copy-number variations (CNVs) are major contributors to disorders of the nervous system, including intellectual disability, autism spectrum disorder (ASD), and schizophrenia (SCZ) ( Geschwind and Flint, 2015; Girirajan et al., 2011; Pescosolido et al., 2013) . A fundamental challenge to understanding these disorders is identifying critical genes within a CNV locus whose deletions or duplications drive specific neural phenotypes. One such CNV with resulting syndromes is 7q11.23, where a hemizygous duplication of the 26-28 genes is associated with ASD or SCZ (Merla et al., 2010; Mulle et al., 2014; Sanders et al., 2011) , and their deletion results in Williams syndrome (WS) (Ewart et al., 1993) .
The most prominent features of WS include cardiovascular, metabolic, and brain abnormalities (Morris, 2010; Pober, 2010) . Metabolic deficits include impaired glucose tolerance and higher resting energy expenditure (Kaplan et al., 1998; Palacios-Verdú et al., 2015) . Brain abnormalities include decreased cerebral volume, smaller neurons, and abnormal gyrification (Galaburda et al., 2002; Jackowski et al., 2009; Meyer-Lindenberg et al., 2006; Van Essen et al., 2006) . While imaging studies have shown that several white matter axonal pathways have an altered microstructure (Haas et al., 2014; Hoeft et al., 2007) , it is also appreciated that the corpus callosum (CC) is smaller and abnormally shaped in WS (Marenco et al., 2007; Sampaio et al., 2013) . These anatomical abnormalities likely play a role in WS manifestations of intellectual disability, increased anxiety, attention deficit hyperactivity disorder, and hypersociability.
Systems biology approaches have made some progress in understanding the role of individual genes in CNV-related neurodevelopmental disorders ( Barak and Feng, 2016; Golzio et al., 2012; Malhotra and Sebat, 2012; Tebbenkamp et al., 2014) . Combining disorder-related gene sets with -omic datasets has the potential to glean insights into CNVs or disorders with multi-genic contributions (Gulsuner et al., 2013; Lin et al., 2015; Parikshak et al., 2013; Willsey et al., 2013) . These strategies can provide some spatial and temporal resolution of disease processes but still cannot reveal the role of individual genes.
The goal of this study was to identify and functionally validate neurobiological processes affected in 7q11.23 syndromes. Systems biology analyses revealed molecular coordination and spatio-temporal specificity of gene expression within, and ontologies derived from, the 7q11.23 locus. Specifically, we identified mitochondrial processes as dysregulated in WS and highlight the heretofore functionally uncharacterized gene DNAJC30 (previously known as WBSCR18). DNAJC30 is enriched in neurons where it interacts with the ATP-synthase machinery and facilitates ATP synthesis. We also found that decreased Dnajc30 expression in mice correlates with altered mitochondrial and neuronal function and morphology. Finally, several aberrations seen in Dnajc30 knockout mice were present in post-mortem brain tissue and primary cells from WS patients.
RESULTS

Integrated Co-expression and PPI Analyses Identify 7q11.23 Gene Clusters with Distinct Functions
The human spatio-temporal expression patterns of the 26-28 protein-coding genes within the 7q11.23 CNV have not been analyzed in detail. Therefore, we used the BrainSpan resource (www.brainspan.org) to analyze RNA-seq data from the developing human brain. Pairwise co-expression among all 7q11.23 genes, followed by hierarchical clustering, identified three clusters ( Figure 1A ). We found that 5 of 6 genes from cluster 1 and 6 of 7 genes from cluster 2 were expressed, whereas only 6 of 14 genes from cluster 3 were expressed (Figures S1A-S1B).
To determine whether each cluster was merely co-expressed or represented functional coordination, we looked at co-expression of each cluster with nearest neighbors on the BioGRID protein-protein interaction (PPI) network. No proteins encoded in 7q11.23 are known to directly interact with each other, but by extending the PPI network to second-and third-order interacting proteins, we still observed high co-expression for clusters 1 and 2, whereas cluster 3 and intercluster-interacting proteins had much lower co-expression ( Figure 1B ). This molecular coordination of clusters 1 and 2 was higher than that of randomly sampled genes across the genome with matched numbers of interacting proteins and is also unlikely to be explained by genomic adjacency (Figures 1C and 1D) .
We next investigated where and when the expression of genes within these clusters might have more pronounced effects. Using the GTEx dataset, we found variations in cluster expression across non-central nervous system tissues, but clusters 1 and 2 were enriched over cluster 3 in many adult brain regions (Fig- ure S1C and other tissues not shown). Next, using BrainSpan data, we created four spatial groups ([1] neocortex (NCX), [2] hippocampus and amygdala, [3] striatum and thalamus, and [4] cerebellum) across nine time windows to look for cluster expression specificity and found that whereas cluster 2 is enriched across all brain regions prenatally, cluster 1 is enriched in the NCX post-natally ( Figure S1D ). This trend remained, with lower magnitude, after including PPI partners ( Figure S1E ). We next focused on clusters 1 and 2 given their enriched expression in the human brain. To investigate the molecular functions within these clusters, we performed Gene Ontology (GO) enrichment analysis on the top co-expressed genes for each gene in a cluster. The list of GO terms was then combined and summarized to identify enriched GO terms. For cluster 2, we found enrichment for gene regulation and mitosis processes driven by BAZ1B, RFC2, and GTF2I ( Figure 1F and Tables S1, S2, S3, and S4). The transcription factor GTF2I has been reported to regulate some of the cognitive defects in WS and ASD (Malenfant et al., 2012; Morris et al., 2003) . By comparison, enriched processes for cluster 1 were synaptic transmission and mitochondrial respiration, the latter being a novel potential participant of 7q11.23 phenotypes ( Figure 1E and Tables S1, S2, S3, and S4). The genes driving the enrichment for these processes were STX1A, ABHD11, and DNAJC30, and this was consistent using either the RNA-seq dataset or an exon array dataset (Kang et al., 2011) .
Taken together, we provide evidence for prenatal gene regulation and post-natal synaptic transmission and mitochondrial respiration as potential contributors to 7q11.23 phenotypes (Figure 1G) . Among the genes associated with mitochondria GO terms, DNAJC30 (DnaJ (Hsp40) homolog, subfamily C, member 30) was an intriguing candidate to investigate. DNAJC30 is of the J-domain-containing family of proteins that have a vast array of functions ( Kampinga and Craig, 2010) yet itself has an unknown function. We therefore explored the neurobiology of DNAJC30.
DNAJC30 Localizes to Mitochondrial ATP-Synthase Machinery in Neocortical Neurons
Expression of DNAJC30 mRNA and protein steadily increased from early human fetal development throughout the brain . To identify which cells in the neocortex express DNAJC30, we performed in situ hybridization and detected mRNA in virtually all glutamatergic excitatory projection (i.e., pyramidal) neurons (PNs) and many interneurons, with the strongest signal noticeably in large PNs of layer (L) 3C (Figure 2A ). We found increased DNAJC30 immunoreactivity in L3C PNs of the superior temporal cortex (STC), as well as in PNs (Betz cells) of the L5B primary motor cortex (M1C) (Figures 2B and 2C) . Betz cells are among the largest neurons in the central nervous system. They have the longest axons, extending to the spinal cord to form the corticospinal tract, which is altered in WS. Additionally, PNs in L3C of the association areas, such as STC, have the second largest somata in the NCX and form either ipsilateral or contralateral cortico-cortical projections, the latter of which comprise the anterior commissure or the CC, both of which are smaller in size in WS. Double-immunofluorescence staining of STC showed that DNAJC30 is present in virtually all neurogranin (NRGN) positive PNs and glutamic acid decarboxylase 1 (GAD1) positive inhibitory neurons ( Figures S2D-S2E ). In contrast, there was a paucity of DNAJC30 signal in GFAP-positive neocortical astrocytes or CNP-positive oligodendrocytes (Figures S2F and S2G) . Next, we performed immunogold electron microscopy (EM) to identify the subcellular localization of neocortical DNAJC30. Gold particles labeled the inner mitochondrial membrane in both dendrites and somata of PNs ( Figures 2D-2F ), building on recent high-throughput studies (Calvo et al., 2016; Huttlin et al., 2015) and supporting our hypothesis that mitochondria malfunction may contribute to 7q11.23 disorders.
To identify DNAJC30-interacting proteins, we performed a yeast-two-hybrid (Y2H) screen and found that the protein that (B) The co-expression of all genes in each cluster and their PPI network. Boxes represent the 25 th and 75 th percentiles. Whiskers represent the 10 th and 90 th percentiles. Points are outliers. All cluster 1 proteins are connected by a distance of 3 on the PPI network. (C) The mean co-expression for clusters 1 and 2 is higher than null expectation, plotted as in (B). (D) Genes of the 7q11.23 locus are colored by cluster, with gene names from clusters 1 and 2. (E and F) GO analysis of the top 1,000 co-expressed genes for each gene in clusters 1 and 2, respectively. Larger nodes denote higher-term frequency. (G) Summary of Figure 1 and Figure S1 . See also Tables S1, S2, S3, and S4 and Figure S1. interacted with DNAJC30 most frequently, and with the highest affinity, was the mitochondrially encoded ATP synthase 6 (MT-ATP6; also known as ATP6) ( Figure 2G ). MT-ATP6 is the H +_ loading component of the F-type ATP synthase (Complex V), which is also located at the inner mitochondrial membrane, and is composed of the transmembrane H + -translocating F 0 subunit and the ATP-generating F 1 subunit in the matrix ( Figure 2H ) (Walker, 2013) . Mutations in MT-ATP6 are associated with Leigh syndrome (de Vries et al., 1993) , a condition characterized by progressive loss of mental and movement abilities (psychomotor regression) during early post-natal development; the developmental syndrome of neuropathy, ataxia, and retinitis pigmentosa (NARP) (Holt et al., 1990) ; and Charcot-Marie-Tooth progressive axonal neuropathy (Pitceathly et al., 2012) . Another interacting protein from the Y2H screen was ATP5G2, which encodes a c-ring protein that is also part of the F 0 subunit of ATP synthase, further suggesting that DNAJC30 is a part of the mitochondrial ATP-synthase complex. We then used co-immunofluorescence and co-sedimentation to confirm DNAJC30 interactions with ATP synthase subunits (Figures 2I-2J and S3A-S3C). Of note, DNAJC30 is predicted to only exist in tetrapods, and although protein homology is high across species, some variations exist that may alter interactions or functions across species (Figures S3D and S3E) . To further confirm the interaction between DNAJC30 and ATP synthase, we isolated mitochondria from human STC and immunoprecipitated the intact ATP synthase. We captured proteins of both F 0 and F 1 subunits as well as DNAJC30 ( Figure 2K ) and were able to confirm another interacting protein from the Y2H screen, the magnesium transporter MRS2. This result was expected, in part, given that when ATP is synthesized, it is complexed with Mg 2+ to make it biologically active. We also found that overexpressed MT-ATP6 co-immunoprecipitated with the F 0 subunit ATPc and DNAJC30 ( Figure 2L ). Together, these data localize the interaction of DNAJC30 and ATP synthase in human neocortical neurons. Comparing the expression of DNAJC30 to ATP synthase and other genes in the oxidative phosphorylation (OXPHOS) pathway, we found that DNAJC30 does not follow the trend of the majority of OXHPOS genes, which decrease their expression in late adulthood. Several OXPHOS genes exhibit spatio-temporal enrichment (Figures S2H and S2I) .
Morphological Defects of Neocortical Projection Neurons in the Dnajc30-Deficient Mouse
Having established DNAJC30 interaction with ATP synthase, we next examined the effects of decreased Dnajc30 expression in mice. We generated two independent lines of knockout (KO) mice and confirmed their decreased Dnajc30 expression by droplet digital PCR (ddPCR) ( Figure S4A ). These mice contained a b-galactosidase cassette in place of the single Dnajc30 exon, and using an X-gal stain to visualize Dnajc30 expression revealed expression in gray matter structures, with the highest amount in the NCX. Within the NCX, X-gal reactivity was higher in L2-3 and L5 than in L4 and L6, consistent with the human expression pattern of more DNAJC30 expression in larger PNs. Similarly, we observed X-gal in both NRGN-positive PNs and GAD1-immunopositive interneurons, but not in ALDH1L1-immunopositive astrocytes ( Figures S4B-S4D ). Body weight was decreased by $20% in KO mice beginning at post-natal days (P) 9-10 and persisting until at least 2 months old (Figures S4E and S4G) . Similarly, extracted brains from both lines of mice were also $20% smaller in KO littermates ( Figure S4F ). We performed all subsequent experiments on line 2, convinced that both lines were similar in expression and gross phenotypes. We also focused on comparisons between WT and KO mice given that the differences observed in heterozygous mice were not frequently significant (see also Figure S4H , explained below).
To investigate the effects of Dnajc30 on neuronal morphology, we performed Golgi staining and then quantified dendrites of PNs ( Figure 3A ). Morphometric analyses showed that KO mice have fewer spines on the principal apical dendrite ( Figure 3B ), whereas the total number of nodes and ends and total length were also significantly reduced by roughly 50% (Figures 3C-3E) . Additionally, the number of basal dendrites ( Figure 3G ), as well as the number of nodes and ends and total dendritic length ( Figures 3H-3J ), were significantly reduced in KO mice, which also have smaller soma areas ( Figure 3F ).
We also bred Dnajc30 mice to Thy1-YFP-H reporter mice to specifically label the soma and all processes of neocortical L5 PNs. L5 neocortical PNs have axons that can project to subcerebral brain regions or intracortically, including via the CC. To determine the effect of Dnajc30 levels on these specific neurons, we measured soma size and thicknesses of the NCX, CC, and L5. Whereas the overall thicknesses of the NCX, CC, and L5 trended toward a reduction, soma size was significantly reduced in KO mice, as was seen with Golgi measurements (data not shown). However, we found that KO mice had a disproportionately lower ratio of CC:NCX ( Figure 3K ). To determine whether this defect was specifically in axons, we performed EM on transected CCs ( Figure 3L ) and found that the g-ratio (axon perimeter/ axon+myelin perimeter) was significantly reduced in KO mice (legend continued on next page) ( Figures 3M and 3N ), confirming they have smaller axon calibers. This result was supported by a significant and population-wide shift toward smaller axon perimeter in KO mice ( Figure 3O ). In sum, decreased Dnajc30 expression resulted in less complex dendritic architecture, and a smaller corpus callosum, recapitulating a major neuroanatomical feature of WS.
Dnajc30 Is a Regulator of Mitochondrial Respiration
To search for underlying molecular abnormalities that may explain neuro-morphological defects in Dnajc30 KO mice, we analyzed cultured primary neurons for their oxygen consumption, mitochondrial membrane potential, and reactive oxygen species (ROS) generation ( Figure 4A ). Using the Seahorse Mito Stress assay, we found that basal oxygen consumption rate was significantly reduced in Dnajc30 KO neurons. We then sequentially added inhibitors to stress mitochondria, and whereas oligomycin and AntimycinA/Rotenone treatment (OXPHOS-inhibiting drugs) revealed no differences between genotypes, FCCP treatment (maximizes mitochondrial respiration) revealed that KO neurons cannot respire at as high of a rate as WT neurons ( Figure 4B ). Mitochondrial membrane potential and ROS production, byproducts of ATP synthesis that can function in a variety of pathways throughout the organism (Shadel and Horvath, 2015) , did not reveal differences between genotypes ( Figures 4C and 4D ). Next, fresh mouse cortices were dissected followed by mitochondria extraction and analysis (Figure 4E) , where ATP production was stimulated then quantified by a kinetic luciferase activity assay. In this minimalized system, ATP production was decreased in mitochondria without Dnajc30 ( Figure 4F ). We next investigated corroborating features of altered mitochondrial function in Dnajc30 KO mice. We first examined mitochondrial morphology ( Figure 4G ), using EM on Thy1-YFP-H-expressing PNs, and found that KO mice exhibited an increase in mitochondria density and a more rounded shape (decreased aspect ratio) ( Figures 4H-4J ). These morphological characteristics are consistent with increased mitochondrial fission, a response to lower-functioning mitochondria. Although cumulative mitochondrial coverage, area, and perimeter remained statistically unchanged (data not shown), the collective EM data are consistent with decreased mitochondrial respiration.
A major ATP-demanding process in PNs is maintaining a negative resting membrane potential, thus providing another readout for altered mitochondrial function. To determine whether membrane potentials were altered, we used perforated patch recordings on Thy1-YFP-positive PNs before and after manipulations of the ATP-sensitive potassium (K + ATP ) channel, a key player in setting the resting membrane potential ( Figure 4K ). After a stabilization period, resting membrane potential in KO mice was significantly more negative, consistent with lower intracellular ATP levels ( Figure 4L ). The K + ATP channel inhibitor tolbutamide resulted in a more positive membrane potential in WT PNs, but not in KO PNs ( Figure 4M ). Furthermore, applying sodium azide (NaN 3 ), a Complex IV inhibitor that indirectly decreases ATP, significantly lowered membrane potential in WT PNs but not in KO PNs ( Figure 4N ), effectively rendering WT PNs similar to untreated KO PNs and suggesting that KO PNs have decreased levels of ATP.
Systemic Metabolic Defects Are Minimal in Dnajc30 Knockout Mice
We observed that deleting Dnajc30 in neocortical PNs results in diminished mitochondrial and neuronal function; these are features also observed in specific cell populations within the hypothalamus and correlate with obesity, diabetes, and glucose regulation (Nasrallah and Horvath, 2014) . Given that (1) WS patients also present with overlapping systemic metabolic abnormalities; (2) DNAJC30 and 7q11.23 cluster 1 genes have enriched expression in the hypothalamus and to a lesser degree in the pituitary, adrenal, and thyroid glands; and (3) Dnajc30 KO mice have decreased body weight, we examined whether KO mice display peripheral metabolic deficits. We first challenged mice with a glucose tolerance test (GTT) and found a trend for female KO mice to have lower blood glucose levels and for male KO mice to have higher blood glucose levels . We also challenged mice with an insulin tolerance test (ITT) and found no difference in the response in females but a stronger trend for male KO mice to have higher blood glucose levels ( Figures S5E-S5H ). Though no differences were observed, probing with specific diets might uncover deeper insights of glucose metabolism in male Dnajc30 KO mice.
To complement the GTT and ITT studies, we also analyzed mice using metabolic chambers. Here, mice were individually housed in a controlled and measured environment to record several physiological features. Although we found no differences across all features, including respiratory exchange ratio (VCO 2 /VO 2 ) (Figures S6A-S6E), food intake ( Figure S6F ), and locomotor activity ( Figure S6I ), two interesting trends emerged. First, Dnajc30 KO mice consumed $25% less water over a 24 hr period ( Figure S6G ), and second, KO mice had higher energy expenditure ( Figure S6H ). This latter feature is observed in the WS population, and perhaps with deeper investigations, differences between genotypes in mice may come to light. Taken together, although we observed no differences in peripheral metabolism, some of the more deviating features may work cumulatively to produce mice with lower brain and body weights. (H) Representative EM images from DAB-labeled neurons. Mitochondria are shaded brown. The nucleus is shaded green (scale = 500 nm). (I and J) Mitochondrial density and aspect ratio, respectively. WT, n = 394 mitochondria/25 cells/5 mice; KO, n = 501 mitochondria/30 cells/6 mice. (K) Illustration of the ATP-sensitive K + channel (blue) and effects of compounds used. (L) Resting membrane potential (WT, n = 33 cells/15 mice; KO, n = 29 cells/17 mice). (M) Effect of tolbutamide (0.1 mM) on membrane potential (WT, n = 14 cells/8 mice; KO, n = 11 cells/7 mice). (N) Effect of NaN 3 (1 mM) on membrane potential (WT, n = 7 cells/4 mice; KO, n = 7 cells/6 mice). All error bars represent ± SEM. *p < 0.05; ****p < 0.0001. Statistical analyses were performed using Student's t tests and multiple t tests and corrections using the Holm-Sidak method.
Social Alterations and Anxiety-like Behaviors in Mice Lacking Dnajc30
A prominent behavioral feature of WS patients is hypersociability. To determine whether Dnajc30 KO mice displayed similar behavior, we employed sociability and social novelty tests. Here, mice are tested in three phases: (1) acclimation to an empty 3-chambered arena, (2) a choice between an isolated stranger mouse and an empty cage, and (3) a choice between the same stranger mouse and a new stranger mouse ( Figures  5A and 5D ). As previously reported, WT mice spent significantly more time in the area and sniffing the stranger mouse than they did with the empty cage ( Figures 5B and 5C ). The KO mice, though showing a strong trend, had no statistical preference between the mouse and the cage. Conversely, when the second stranger mouse was introduced, KO mice had increased preference for time spent with that mouse and a trend for increased sniffing of that mouse ( Figures 5E and 5F ), which might reflect an interest in a novel social interaction.
Another behavioral feature of WS patients is increased anxiety. To test whether Dnajc30 KO mice model this behavior, we used the open field test, in which mice freely explore a novel empty area ( Figure 5G ). Consistent with an anxiety-like phenotype, KO mice exhibited less exploratory behavior (traveled less distance) and spent more time close to the walls during the 5 min test period, and this persisted after 30 min of habituation ( Figures 5H and 5I ). We also employed another test for anxiety-like behavior, the elevated zero maze, and found a strong trend for KO mice to spend more time in the closed arms ( Figures  5J and 5K ). We probed this behavior further using a marbleburying task ( Figure 5L ). Although this task has been used to measure anxiety-like behavior, it more accurately reflects repetitive, perseverative behaviors reflective of an obsessive-compulsive phenotype (Thomas et al., 2009) . Therefore, if KO mice display more anxiety-like behavior, their thigmotaxis would override their innate digging behavior. Indeed, KO mice buried fewer marbles than WT counterparts ( Figure 5M ). Of note, the increased anxiety-like phenotype may also confound social interactions, contributing to more variable responses in the social tests.
These anxiety tests can be confounded by hypomobility. To assess this confounder, we trained mice in an active avoidance test, which requires them to learn and remember that a tone will precede a foot shock. Movement to another chamber within 10 s avoids the foot shock, but the mouse can also escape to another chamber while receiving the foot shock ( Figure 5N ). For each of the 7 days, we found no difference between WT and KO mice in successful avoidance or percentage of escapes ( Figure 5O ), suggesting that KO mice exhibit normal mobility and can learn, consistent with normal home-cage locomotor activity observed in in KO mice ( Figure S6I ). We also found no significant difference between WT and KO mice in latency to fall on the rotarod test ( Figures S6J and S6K ). Together, these results suggest that the loss of Dnajc30 alters the neural circuitry related to social and anxiety-like behaviors, while sparing circuitry related to learning and memory and movement and motor coordination.
Neuronal and Molecular Deficits in Williams Syndrome
Given that Dnajc30 KO mice phenocopy the CC defect and some of the behavioral deviations in WS patients, we next interrogated whether similar underlying cellular features were present in WS tissue. First, we acquired skin fibroblasts from unaffected donors and patients having a typical WS deletion and used cellular reprogramming and directed differentiation to generate cortical neural cells ( Figures S7A-S7B ). DNAJC30 expression was decreased in iPSC-derived cortical cells and fibroblasts by about 60% (Figures 6A and 7A ). Morphometric analysis on iPSCderived neurons immunopositive for BCL11B (CTIP2), a transcription factor enriched in L5B PNs, revealed that although not every metric was decreased in WS cells, the number of nodes and total dendritic length were reduced, as seen in Dnajc30 KO neurons (Figures 6B-6E and data not shown).
After confirming that DNAJC30 expression is also decreased in post-mortem WS NCX tissue, we used a modified Golgi-Kopsch stain to compare PN morphologies in situ ( Figures 6F  and 6G ). In the deep layers of M1C, there was a reduction in apical dendrite nodes, ends, and total length (Figures 6H-6J). We also performed Nissl stains on STC and M1C from control and WS brains. Cell area measurements revealed that L3C and L5 PNs from STC and L3 and L5B cortical PNs from M1C were significantly smaller in WS brains ( Figures 6K, 6L , 6N, and 6O). We also saw a trend for increased neuron density in all measured layers of WS NCX, with a statistical difference in L5 STC neurons ( Figures 6M and 6P ). Taking these data together, we found cellular deficits in WS tissue similar to those in Dnajc30 KO mice.
To draw better parallels between Dnajc30 KO mice and WS cells, we performed a suite of mitochondrial analyses. Similar to Dnajc30 KO neurons, we found decreased basal respiration and maximal respiratory capacity in WS primary fibroblasts, while observing no difference in membrane potential, increased ROS generation, and decreased ATP synthesis ( Figures 7B-7E ). The increased ROS, though not observed in KO mice, may suggest (legend continued on next page) broader OXPHOS aberrations in WS. These similarities implicate mitochondrial malfunction as participating in WS pathogenesis.
The functional differences in the OXPHOS pathway prompted us to search for potential differences in the integrity or abundance within OXPHOS complexes. OXPHOS complexes work most efficiently as supercomplexes (multimers), where ATP synthase forms a dimer at the center-most folds of cristae (Hahn et al., 2016) , and Complexes I, III, and IV form supercomplexes in a range of ratios such as 1:2:0 or 1:2:4 (Chaban et al., 2014; Schä gger, 2002) . Here, fibroblast mitochondrial proteins were differentially solubilized in Dodecyl b-D-maltoside (DDM), separated through BlueNative-PAGE, and analyzed by western blot. While we did not observe any difference in monomeric Complex V abundance, there was a trend for increased monomeric Complexes III and IV in WS, and this difference was not due to expression differences in the specific proteins to which the antibodies were targeted ( Figures  7F-7H ). It has been shown that, because ATP-synthase dimers help anchor cristae folding, and therefore stabilize supercomplexes, destabilizing the dimer can indirectly disrupt supercomplexes (Cogliati et al., 2016) . To determine whether ATP-synthase dimers are altered in WS, thus affecting the supercomplex abundances containing Complexes III and IV, we used low and high digitonin treatments to liberate ATP synthases from the inner mitochondrial membrane. In low digitonin, we saw a trend for more dimers in WS, and this trend is reversed in high digitonin ( Figure 7I ), suggesting that dimers are less stable in WS, and that the decreased stabilization can affect supercomplex formation. We subsequently found statistically significant changes in Complex III and IV abundance in WS neocortex ( Figures 7J, 7K and S7C-S7E), perhaps highlighting the sensitivity of brain tissue to mitochondrial aberrations. Furthermore, ATP synthase dimers were less stable in WS neocortex (Figures 7L and 7M) . In support of DNAJC30 aiding dimerization, DNAJC30 was observed at a molecular weight similar to those of Complex V monomers (Figures S7F-S7G) and was less abundant in WS samples. We expected similar results in Dnajc30 KO mice; however, no differences were observed between WT and KO mitochondria in Coomassie-stained gels or in western blots of these native gels for specific proteins expected to be in close, or direct, interaction with Dnajc30 ( Figures S7H and S7I) . These results suggest that although mitochondrial function is compromised in mice without Dnajc30, it may not be solely due to its interaction with ATP synthase. To that end, we also observed in human NCX BN-PAGE western blots of DNAJC30 that it also co-migrated with supercomplexes and some lower-molecular-weight species ( Figure S7G ). Given that most supercomplexes contain Complex I, we performed immunoblots for the Complex I protein NDUFB8 on low-and high-digitonintreated samples from mice and found a trend for changes in the largest Complex I-containing supercomplexes ( Figures  S7J and S7K ). Performing the same experiment on human NCX preparations revealed decidedly apparent differences in Complex I-containing supercomplexes ( Figures 7N-7O) .
To reconcile the difference in mouse and human ATP-synthase dimerization, we searched the literature and found a report that identified RCC1L as a guanine nucleotide exchange factor for OPA1, the known mitochondrial fusion protein (Cipolat et al., 2004; Huang et al., 2017) . This report showed that decreased RCC1L can phenocopy mitochondrial defects observed in Opa1 knockout cells, which themselves can exhibit decreased ATP-synthase dimers and dissociation of OXPHOS supercomplexes (Cogliati et al., 2013) . RCC1L lies $225 kb away from the telomeric boundary of a typical WS deletion (Figure S7L) and thus was not included in our initial analysis. We conceived that RCC1L might be regulated by elements within the WS locus or by a GTF2 gene product from the WS locus. Western blots showed no differences in RCC1L expression between control and WS NCX ( Figure 7P ). We also did not find RCC1L to be differentially expressed between control and WS samples in published gene-expression datasets (Adamo et al., 2015; Chailangkarn et al., 2016 ) ( Figure 7Q ). Although these results do not completely dispel the possibility that RCC1L and DNAJC30 function in concert to preserve OXPHOS supercomplexes ( Figure S7L ), they do emphasize DNAJC30 as having a role in maintaining OXPHOS supercomplex stability.
DISCUSSION
In this study, we combined human brain transcriptomics and PPI datasets to reveal a role for mitochondria in normal human brain development and WS. Mitochondrial participation is driven in part by the heretofore functionally uncharacterized gene DNAJC30. We revealed that DNAJC30 is highly enriched in neurons and is an auxiliary protein of the ATP-synthase complex. Decreased DNAJC30, whether in KO mice or tissue from WS patients, resulted in decreased ATP as well as deviations in neuronal morphology, electrophysiology, and mitochondrial function. These data demonstrate mitochondrial dysfunction as part of the pathogenesis of WS, and they have implications for mitochondria in 7q11.23 duplication syndromes and similar neurodevelopmental disorders.
Mitochondrial contribution to aging and neurological and psychiatric disorders, such as Huntington's disease, Parkinson's disease, Alzheimer's disease (AD), and SCZ, has been previously established (Manji et al., 2012; Riera and Dillin, 2015; Wallace, 2005) . Ab peptides (cleaved from the AD-linked amyloid precursor protein) are also reported to be direct interacting partners with 7q11.23 proteins ABHD11, LIMK1, and DNAJC30. These protein interactions cluster within our ''mitochondrial'' GO categories, and in light of mitochondria playing a role in both WS and AD, there may be some genetic interactions between the 7q11.23 locus and AD-linked loci. This hypothesis is supported in a report describing pathological hallmarks of Ab plaques in a 35-year-old patient with WS (Golden et al., 1995) . Alternatively, (O) Soma area from L3 and L5B Nissl-stained neurons (Ctrl L3, n = 185 neurons/3 specimens; WS L3, n = 190 neurons/3 specimens; Ctrl L5, n = 199 neurons/3 specimens; WS L5, n = 200 neurons/3 specimens). (P) Neuron density in L3 and L5B M1C (Ctrl, n = 2 areas each for 3 specimens; WS, n = 2 areas each for 3 specimens). Data are plotted as ± SEM. *p < 0.05; **p < 0.01; ****p < 0.0001 using a Student's t test.
it is reported that WS patients also exhibit several features of mild-accelerated aging, which may be caused by dysfunctional mitochondria, and this dysfunction may subsequently facilitate neurodegenerative hallmarks.
In SCZ, several pieces of evidence suggest that mitochondria can have an instrumental role. Metabolic genes have significantly decreased expression in the prefrontal cortex in postmortem SCZ tissue (Arion et al., 2015; Middleton et al., 2002) . Furthermore, the transcriptome alterations in mitochondrial energy-production genes found in the dorso-lateral prefrontal cortex layer 3 neurons from SCZ are distinct compared to those from bipolar disorder and major depressive disorder (Arion et al., 2017) . It is also known that variants in mitochondrial DNA (mtDNA) that cause bona fide mitochondrial disorders such as Leigh syndrome or mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) often display psychiatric comorbidities, including SCZ (Verge et al., 2011) . Other mtDNA variants, including in MT-ATP6, have also been associated with SCZ outright (Ueno et al., 2009) . Furthermore, alteration in the levels of the mitochondrial protein uncoupling protein 2 (UCP2), which controls substrate oxidation of the mitochondria in neurons (Andrews et al., 2008) , as well as mitochondrial fidelity overall, have significant impact on cortical structure and function (Hermes et al., 2016; Li et al., 2004; Varela et al., 2016) . These findings illustrate that mitochondrial function can facilitate neuropsychiatric disorders, including major depressive disorder (Cai et al., 2015; CONVERGE consortium, 2015) and intellectual and developmental disability (Ouyang et al., 2016) , and substantiate the need for further investigations into similar disorders, such as ASD.
Investigations into mitochondria and ASD are relatively unchartered. Gene-expression studies revealed misexpression of several nuclear and mtDNA genes in post-mortem ASD brains (Legido et al., 2013) . Others have used the human brain transcriptome to investigate unifying mechanisms of ASD and found that ASD candidate genes were enriched in co-expression modules of mitochondrial function (Mahfouz et al., 2015; Schwede et al., 2018) . However, few studies have revealed molecular mechanisms for how mitochondria can impact ASD (Ebrahimi-Fakhari et al., 2016; Lin-Hendel et al., 2016; Novarino et al., 2012) .
Our results provide the basis for exploring therapeutic options for WS, several of which are already being tested for mitochondrial disorders (DiMauro et al., 2013) , including Leigh syndrome. Because DNAJC30 is an auxiliary component of ATP synthase, compared to the central protein MT-ATP6, it might be expected that the metabolic phenotypes in WS would be milder than those in Leigh syndrome. Nevertheless, the molecular process is similar, and thus it is possible that therapies for Leigh syndrome might also benefit WS. The potential of therapeutic intervention in WS is buoyed by our finding that cluster 1 genes, including DNAJC30, are enriched post-natally, providing a larger time window to maximize treatments.
A specific question remains about how removing Dnajc30 in mice resulted in mitochondrial malfunction, if not through obvious changes in OXPHOS supercomplexes. We are unfortunately limited in visualizing with which proteins the mouse ortholog of DNAJC30 interacts. Neither of the antibodies we used, which reliably detected the human and monkey protein in native or denatured conditions, provided reliable signal for native or fixed endogenous mouse protein. Although these proteins share high homology, there are amino acid differences that may lose the epitope in mice and, consequently, alter its function and interacting proteins. For example, there is a seven-residue deletion in mouse of the human sequence T 37 YSQGDC 43 , which contains a number of polar residues just N-terminal to the J-domain. Also, variations S82P and T105I (residues 75 and 98 in mouse, respectively) in the middle of the J-domain are potential phosphorylation sites. One can hypothesize several effects of variations, but their elucidation may require structural biology techniques.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: Figure S7 . 
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Human tissue
De-identified post-mortem brain tissue was from the NIH Neurobiobank (neurobiobank.nih.gov), or from the Sestan lab collection, details of which have been published (Kang et al., 2011) . Tissue was collected after obtaining parental or next of kin consent, and with approval by the institutional review boards/committees of Yale University School of Medicine, the Telethon Network of Genetic Biobanks (fibroblasts only), and National Institutes of Health. The post-mortem interval (PMI) was defined as hours between time of death and time when tissue samples were frozen. Tissue was handled in accordance with ethical guidelines and regulations for the research use of human brain tissue set forth by the NIH (http://bioethics.od.nih.gov/humantissue.html) and the WMA Declaration of Helsinki (http://www.wma.net/en/30publications/10policies/b3/index.html). Appropriate informed consent was obtained and all available non-identifying information was recorded for each specimen. Male and female specimens were used in these studies, but analyses into the influence of sex were not performed due to limited sample number and our efforts to reveal differences independent of sex. Gender identity was not analyzed because all samples were de-identified. Meta-data on the samples, all of which are de-identified, can be found in Table S6 .
Rhesus macaque tissue
Post-mortem brain tissue was from the Sestan lab or Arnsten lab collections. Tissue was collected at pre-determined ages and in accordance with a protocol approved by Yale University's Committee on Animal Research and NIH guidelines. Animals were deemed healthy as per Yale Animal Resource Center veterinarians. The sample used for immunofluorescence was from a healthy and experimentally naive 1-year-old male where the brain was extracted and immersion fixed in 4% paraformaldehyde/PBS followed by 30% sucrose/PBS. The samples used for immuno-gold EM were from two healthy and experimentally naive female young-adult (9 and 11-year-old) rhesus macaques. Macaques were anesthetized with sodium pentobarbital (3 0mg/kg, i.v.), and perfused transcardially with oxygenated artificial cerebrospinal fluid, followed by 4% paraformaldehyde/0.05% glutaraldehyde, plus 0.2% picric acid in 0.1 M phosphate buffer (PB). All perfusates were administered ice-cold. The brains were blocked coronally, vibrosliced at 60 mm, cryoprotected in sucrose, and stored at À80 C. 
Cell lines
ReNcell CX cells (human neural progenitor cell line, male sex) were purchased from Millipore and cultured in ReNcell NSC medium with fibroblast growth factor-basic (1 ng/mL) and epidermal growth factor (2 ng/mL). HEK293T cells (female sex) were purchased from ATCC and cultured in DMEM supplemented with 10% FBS, 1% penicillin/streptomycin, and 1% L-glutamine. Human primary fibroblasts were obtained from NIH Neurobiobank and from the Genomic and Genetic Disorders Biobank (GGDB, Telethon Network of Genetic Biobanks (TNGB), project no. GTB07001G). Fibroblasts were from male and female sexes, for details see Table S6 . All specimens were collected under guidelines approved by institutional review boards and anonymized prior to our receipt. Cell lines were used directly from purchasing centers (Millipore, ATCC) or internationally reputable biobanks (NIH, TNGB), which provided authentication documents with shipment. Fibroblasts were cultured in aforementioned DMEM. DPBS (1x) was used to wash cells of media, and 0.25% trypsin was used to passage cells. All cellular reprogramming was initiated on low passage cells (%8) (except lines GDB361, passage % 12; and UMB5437, passage unknown). Cells were maintained in 5% CO 2 and humidified 37 C incubators. Fibroblast reprogramming and culture conditions are described below.
Mice
All experiments using animals were carried out in accordance with a protocol approved by Yale University's Committee on Animal Research and NIH guidelines. The Dnajc30 knockout mouse strains used for this research project were created from ES cell clones 16795A-A9 and 16795A-F1, obtained from the NCRR-NIH supported KOMP Repository (www.komp.org) and generated by Regeneron Pharmaceuticals, Inc. for the NIH funded Knockout Mouse Project (KOMP). Methods used to create the Velocigene targeted alleles have been published (Valenzuela et al., 2003) . The ES cells were used to create chimera at Yale Genome Editing Center, which were then backcrossed to make congenic C57BL/6N mice. Some heterozygous males were returned to KOMP as a part of their resubmission and sharing program. The Thy-1-YFP-H transgenic mice were obtained from the Jackson Laboratory. Mice were reared in group housing in a 12h light:12h dark cycle and provided food and water ad libitum with veterinary care provided by Yale Animal Resource Center. Only mice in good, healthy condition, as approved by Yale Animal Resource Center, were used for breeding and experimentation. Multiple breeding pairs were maintained and siblings were never mated to increase genetic diversity, and prevent unintended selection for features that could affect results. Both sexes were used and randomly assigned for all experiments. Different post-natal ages were also used, depending on the assay (details below). No drugs were used in this study, and mice were naive for the open field test, but the same cohort was used for social interaction and rotarod behavior tests. A different, naive, cohort was used for the active avoidance test, and a subset of these mice were used for metabolic chambers. Male and female mice were used throughout this study, but the influence of sex was only monitored in metabolic analyses, where sex differences are well-documented.
METHOD DETAILS Expression and protein network analysis
Gene expression analysis was performed on the exon array (Kang et al., 2011) and publicly available BrainSpan RNA-seq datasets (www.BrainSpan.org) using the RNA-seq data for data presentation. We calculated the pairwise co-expression coefficient (Pearson correlation coefficient) among all 7q11.23 CNV genes and performed hierarchical clustering (Ward's method) with the distance being defined as 1 -co-expression coefficient. We used log2 transformed RPKM values for the co-expression calculation. The three clusters were identified by visual inspection of the dendrogram and heatmap.
Integration of the brain transcriptome and protein-protein interaction network was done using the non-redundant physical BioGRID protein-protein interaction network (3.4.132, Jan. 2016) as a backbone interactome (Stark et al., 2006) . We confined the interactome space based on the availability and the abundance of the BrainSpan RNA-seq dataset. We first removed all the nodes (proteins and corresponding genes) that are not profiled in the BrainSpan RNA-seq dataset from the interactome. We further refine it by removing genes with noise expression levels by grouping as expressed versus non-expressed using a mixture model. This resulted in an interactome network of 12,367 nodes and 159,353 edges. We found that within the resulting interactome network, the pairwise coexpression of nodes significantly decayed over the shortest path distance between the nodes, consistent with several reports showing that the proximity of genes in the interactome network is indicative of the functional similarity of genes. We found similar results when using expression level cutoff of RPKM > 1 (data not shown). Data presented are without removing non-expressed genes to demonstrate the contribution of all genes in the 7q11.23 locus.
We tested the significance of the observed mean pairwise co-expression of gene set (i.e., the group of genes belong to a cluster) against an empirical null expectation. To draw a null expected mean co-expression for a set of genes in a cluster, we randomly sampled a set of matched number of genes having the same number of protein interacting partners from the interactome network and averaged the absolute value of the pairwise co-expression coefficients. The significance p value of the co-expression of the cluster is then determined by 1 -the number of times the mean absolute co-expression of null sets larger than that of a cluster gene set divided by the number of randomly sampled null sets. Here we used 1000 null sets.
We examined the relative tissue-specific gene expression enrichment between groups of genes using Genotype-Tissue Expression (GTEx) project RNA-Seq dataset (GTEx Consortium, 2013) . We downloaded GTEx V6 Analysis RNA-Seq dataset available from http://www.gtexportal.org/home/datasets/GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct.gz. We summarized the expression values of genes per tissue group and performed the Wilcoxon rank sum test between two groups (i.e., C1 and C2 combined versus C3 cluster) upon the quantile-normalization of the per-tissue mean expression values.
Identifying spatio-temporal context of 7q11.23 genes was done by grouping all the BrainSpan RNA-seq dataset into 36 spatiotemporal intervals: 4 spatial groups [(i)neocortex, (ii)hippocampus and amygdala, (iii)striatum and thalamus, and (iv)cerebellum)] and 9 temporal windows (8 pcw -40 years; see www.BrainSpan.org). We then evaluated the specificity of gene expression of all genes in the interactome network using geneEnrichment profiler (Benita et al., 2010) , which provides a quantitative measure of up-downregulation in a given spatio-temporal interval with respect to all the rest intervals. We standardized the specificity scores with mean = 0 and standard deviation = 1 in each spatio-temporal interval. Therefore, the resulting gene-expression specificity score of each gene provides a deviation (Z-score) from the normalized specificity score distribution in a given spatio-temporal interval. Analysis of co-expressed genes was performed by retrieving normalized log2 signal intensity and RPKM values from BrainSpan datasets (exon array and RNA-seq, respectively), and then using a Pearson correlation, identifying the top 1000 correlation coefficients for each 7q11.23 gene. These gene lists were analyzed for GO terms using the Functional Annotation Tool within DAVID v6.7 (Huang et al., 2009) . We reached similar observations from both exon array and RNA-seq platforms. All results were then filtered for FDR < 0.01, and all subsequent GO terms associated with genes from one cluster were submitted simultaneously to REVIGO (Supek et al., 2011) , using medium similarity (0.7), and SimRel semantic similarity measures. The provided.xgmml files were imported into Cytoscape v3.3 for plotting (Shannon et al., 2003) .
DNAJC30 protein sequences of human (Uniprot: Q96LL9), rhesus macaque (Uniprot: F6WFD4), cow (Uniprot: Q3SZ23), and mouse (Uniprot: P59041) were aligned using ClustalW , and analyzed with Jalview (Waterhouse et al., 2009) .
Western blotting
Unless otherwise described, general western blotting procedures were followed. Cells or tissue were lysed by sonication in PBS or TBS with 0.01% Tween-20 and protease and phosphatase inhibitors. Following centrifugation at 20,000xg, supernatant protein concentrations were quantified and mixed with Laemmli loading buffer, boiled, and electrophoresed on NuPage Bis-Tris gels, followed by protein transfer to PVDF membranes. Membranes were incubated in 5% milk or 5% BSA, incubated with primary and secondary antibodies, and developed using chemiluminescence. Bands were imaged and quantified using a G:Box Chemi XRQ and GeneTools software, respectively.
To immunoprecipitate the ATP synthase complex, intact mitochondria were isolated from human superior temporal cortex in mitochondrial extraction (ME) buffer + protease inhibitor cocktail (225 mM mannitol, 75 mM sucrose, 50 mM KCl, 10 mM KH 2 PO 4 , 10 mM Tris pH 7.4, and 0.5 mM EGTA) by Dounce homogenization (Pestle Ax10, Pestle Bx30). Homogenate was centrifuged at 1000 x g for 10 minutes, and the resulting supernatant centrifuged at 12,000xg for 10 minutes. Pelleted mitochondria were washed and resuspended in ME buffer + 0.05% n-Dodecyl b-D-maltoside and incubated at 4 C for 1 hr to liberate protein complexes from membranes. Proteins were then added to antibody-conjugated Protein G beads following the manufacturer's protocol for overnight incubation at 4 C. Following bead washing (3 x 100 volumes of TBS+0.1% Tween-20), proteins were eluted in 2X Laemmli buffer without b-mercaptoethanol. For these and all subsequent single-image experiments, the data presented are representative of at least three independent experiments.
For Blue-Native gel electrophoresis, mitochondria were isolated in ME buffer as before with modification. Following the final high speed mitochondrial pelleting centrifugation, protein concentrations were determined and equal mass of protein was centrifuged in a new tube. The resulting pellet was resuspended in 50mM Tris, 50mM NaCl, and 1mM EDTA and incubated in specified detergents (DDM or Digitonin) for 30 minutes at 4 C. Detergent concentrations were determined empirically, and we identified that 2% DDM, 4g/g Digitonin (low), or 13 g/g Digitonin (high) produced the required solubilization of protein complexes. Treated samples were then centrifuged at 20,000xg for 30 minutes, and the supernatant was diluted in 4x NativePage sample buffer and Coomassie G-250. NativePage gels were run according to manufacturer's protocol. For western blots, proteins were transferred as before, membranes were rinsed for approximately 5 minutes in 100% methanol before washing in TBST and then milk and continuing with antibody incubation.
Cloning and cell culture
Human DNAJC30 cDNA was purchased from OriGene (SC319163) and subcloned into a pCAGEN expression plasmid. Mouse Dnajc30 cDNA was cloned from a mouse brain-derived cDNA library. Both human and mouse sequences were amplified using PCR where the 3 0 reverse primer had significant overlapping sequence with the 5 0 forward primer for GFP sequence (see Table S5 ). Separately generated human or mouse DNAJC30 and GFP amplicons were then used as templates in a second PCR that amplified across both sequences. MT-ATP6-HA-FLAG cDNA was synthesized by GenScript into pcDNA3.1(+). It was designed with an N-terminal mitochondrial targeting sequence from COX VIII and C-terminal epitope tags HA and FLAG using optimized nuclear codon usage.
Human fetal neocortical neural cells were cultured in ReNcell media supplemented with EGF and FGF on mouse laminin coated dishes. We followed the recommended protocol for Amaxa Nucleofection, using the mouse neural stem cell kit. Cells were plated onto chamber slides, and then 16-24 hr post-transfection cells were fixed with 4% paraformaldehyde (PFA) and incubated in blocking buffer (5% BSA, 1% normal donkey serum in PBS) with 0.01% n-Dodecyl b-D-maltoside before adding primary antibodies. HEK293T cells were cultured in DMEM with 10% FBS on lysine-coated dishes until $80% confluency when plasmids were transfected using Lipofectamine 2000. Cells were analyzed 16-24 hours post-transfection. For immunoprecipitation of MT-ATP6 and DNAJC30, whole cell lysates were prepared in ME buffer with Dounce homogenization followed immediately by adding n-Dodecyl b-D-maltoside to a final concentration of 0.05%. Lysate was then incubated with antibody-conjugated Protein G beads and continued as described above. For GFP and mitochondria co-fluorescence visualization, cells were incubated with MitoTracker (100nM) for 30 minutes, following the manufacturer's protocol. For subcellular fractionation, a 10cm dish of transfected cells were collected and resuspended in 400 mL of TBS + protease inhibitor for Dounce homogenization (10x Pestle A, 30x Pestle B). Homogenate was centrifuged at 4 C for 5 min. at 1000xg creating a pellet 1 (P1) and supernatant 1 (S1). S1 was put in a new tube for centrifugation at 14000xg for 5 minutes creating P2 and S2. P2 was washed twice with TBS and S2 was centrifuged again to enhance purity of each fraction before mixing with Laemmli buffer and loading on polyacrylamide gels.
Immunohistochemistry
Post-mortem brain tissue from adult humans, rhesus macaque, or mouse was used for immunohistochemistry (IHC), immuno-electron microscopy (immuno-EM), and immunofluorescence (IF). Standard procedures were followed for each application. For IHC, human sections were pre-treated with 0.3% H 2 O 2 followed by incubation in blocking buffer (5% BSA, 1% normal donkey serum in PBS + 0.05% Tween-20) at room temperature and then incubation for 24-48 hours at 4 C in primary antibodies. Tissue was then incubated with biotin-labeled secondary antibodies, conjugated with Avidin-Biotin-Peroxidase Complex, and visualized with DAB-nickel following the manufacturer's recommended protocol. Developed sections were mounted on Superfrost Plus charged slides, dehydrated through an ethanol series, cleared with xylenes, and preserved with Permount and glass coverslips. Images were taken using Aperio ScanScope digital scanner.
For immunofluorescence, a block of adult rhesus macaque STC was fixed and incubated in 30% sucrose. The block was then embedded in agarose, sectioned at 25 mm, and perforated by sucrose-protected freeze/thaw treatment. Sections were blocked in blocking buffer using 0.05% n-Dodecyl b-D-maltoside, which was used for subsequent antibody dilutions. DAPI was used at 1 ng/mL. Finished sections were mounted on slides and covered with Aqua-Poly/Mount. Fluorescent images were acquired on a Zeiss LSM 510 multi-photon microscope and modified using Zen software.
Electron microscopy
Sections of the macaque dorsolateral prefrontal cortex (DFC) underwent 3 freeze-thaw cycles in liquid nitrogen to facilitate penetration of immunoreagents, and were subsequently processed free-floating for DNAJC30-immunocytochemistry. Non-specific reactivity was suppressed with 10% non-immune goat serum (NGS) and 2% IgG-free bovine serum albumin in 50 mM Tris-buffered saline (TBS). The sections were additionally treated with 0.5% sodium borohydride in TBS to quench non-reactive aldehydes prior to protein blocking.
For labeling with clustered immunogold, sections were incubated for 36 h at 4 C in anti-DNAJC30 mouse polyclonal antibody, 1:500 in TBS, plus 2% NGS (NTBS), and transferred for 2 h at room temperature (RT) to goat anti-mouse biotinylated F(ab 0 ) 2 fragments, 1:500 in NTBS, and finally to goat anti-biotin IgG conjugated to 1.4 nm gold, 1:200 in NTBS supplemented with 0.07% Tween 20 and 0.1% BSA-c (gold-buffer). To eliminate traces of endogenous biotin, sections were additionally treated with an avidin/biotin blocker prior to the immunoprocedure. After fixation in 1% buffered glutaraldehyde, gold was enhanced under a mercury-vapor safelight for 8-10 min on ice with the HQ Silver autometallographic developer. For labeling with single gold immunoparticles, the sections were washed after the primary antibody in gold-buffer (see above) and incubated for 2 hr at RT with goat anti-mouse Fab 0 conjugated to 1.4 nm gold. Gold was fixed and enhanced as described above.
Labeled sections were mounted on glass slides for imaging under an Axiophot photomicroscope equipped with Axiocam HRc digital camera or processed for electron microscopy and embedded in Durkupan epoxy resin. Layers II/III of the DFC, were sampled for re-sectioning and analysis under a JEM1010 transmission electron microscope operating at 80 kV, with or without lead counterstaining. Images were captured at 3 60,000 to 200,000 original magnification with a digital camera (Gatan, Pleasanton, CA), and micrographs were edited using Photoshop CS4 (Adobe Systems, San Jose, CA) for brightness and contrast (applied to the entire panel). No other manipulation was made to raw images.
Yeast-two-hybrid
Yeast-two-hybrid experiments were performed by ProteinLinks, Inc. (Pasadena, CA). We supplied human DNAJC30 cDNA, the entirety of which was used for the bait in a screen against an adult human brain library. Briefly, this Y2H system utilized a tetracycline inducible DNA-binding domain and a tetracycline-induced operon-reporter system. Semiquantitative measurements and raw pictures were provided to the investigators.
Droplet digital PCR
RNA was isolated from tissues/cells essentially as previously described (Kang et al., 2011) . For frozen Dnajc30 mouse cortices and WS neocortex, tissue was pulverized in a chilled mortar and pestle, and homogenized using chilled steel beads and a bead mill homogenizer. All lysates were then subjected to RNA purification using the RNeasy Plus Mini Kit. Concentration and RIN values were obtained using R6K ScreenTape and a TapeStation 2200. One mg of total RNA was used to create cDNA using SuperScript III reverse transcriptase. One ng of cDNA was used for template in droplet digital PCR. Primer/probe sets are available in Table S5 .
LacZ staining
One-month-old mice were anesthetized and transcardially perfused with PBS followed by 4% PFA in PBS. Extracted brains were then incubated at 4 C in 4% PFA for four hours and then washed and stored in PBS with 0.01% sodium azide. Brains were sectioned at 50 mm, washed in LacZ buffer (100 mM phosphate buffer, 2 mM MgCl 2 , 0.02% NP-40), then incubated in the dark at 37 C in LacZ buffer with 5 mM potassium ferricyanide, 5 mM potassium ferrocyanide, and 1 mg/mL X-gal. After color development, sections were washed in LacZ buffer, postfixed in 4% PFA for 1 hr, and stored in PBS at 4 C. Sections were then used for immunohistochemistry and detection using DAB without nickel. For this staining, neuronal and mitochondrial mophometrics, and electrophysiology, we studied dorsal frontal/motor and anterior somatosensory mouse brain regions.
Neuronal morphometrics and corpus callosum analysis
A FD Rapid GolgiStain kit was used to compare neuronal morphologies ($15 neurons per mouse) throughout the neocortex of WT (n = 4) and KO (n = 6) mice aged 9-10 days. The manufacturer's protocol was closely followed, incubating brains in solution A+B for 10 days and solution C for 3 days before sectioning and mounting on gelatin-coated slides. After placing on coverslips, sections were viewed on a Zeiss Axio Imager.A1 and neuronal morphology analyzed with Neurolucida. For this and all other person-based quantification, researchers were blinded to genotype before their analyses.
Mice were crossed with Thy-1-YFP-H to label L5 cortical PNs and their processes. To measure thicknesses of the neocortex, corpus callosum, and L5, serial coronal sections from P9-P10 mice, 5 of each genotype, were mounted and covered on microscope slides, and tiled images taken with a 5X objective on a Zeiss Imager M2 fluorescent microscope. Thickness measurements were made using Zeiss AxioVision SE64 software. To measure soma sizes, mice at 2 months of age were used and images were captured at 40X. ImageJ was used to trace YFP-positive cells and measure their somata. We used five WT mice and eight KO mice, and measured 40 cells per mouse (data not shown but described in text).
To measure axon perimeter of the corpus callosum, 3-week-old mice were transcardially perfused with 4% paraformaldehyde and 2.5% glutaraldehyde, and extracted brains were incubated in fixative overnight or longer at 4 C. Sagittal sections (100mm) were generated on a vibratome (Leica), starting most medial, and placed on microscopes before processing for electron microscopy. Standard osmication and an ethanol dehydration series was performed with 1% uranyl acetate added to 70% ethanol to enhance membrane contrast. Five mice of each genotype were used. Sections were imaged at high magnification (9300X), and measured using the g-ratio plugin for ImageJ (http://gratio.efil.de).
Mitochondrial functional analyses
Primary neuron cultures were made from P0 cortices as described previously. Briefly, P0 cortices were dissected in Hank's Balanced Saline Solution (HBSS), minced with a razor blade, then incubated at 37 C in 0.01% papain, 0.1% dispase, and 0.01% DNaseI in HBSS. Cells were triturated using fire-polished Pasteur pipettes. After 15-30 min, cells were pipetted through a 40 mm filter into tube for centrifugation and resuspension in Neurobasal media. The Seahorse XF Cell Mito Stress Test Kit was utilized per the manufacturer's recommendation. For Seahorse assays, 7.5 x 10 3 P0 neurons were plated on lysine-and laminin-coated Seahorse assay plates, and analyzed between 4-7 days in culture. To calculate maximum respiration, averaged Antimycin A + Rotenone values were subtracted from averaged FCCP values; the differences were compared across genotypes to determine statistical significance. Normalization was performed to combine similar experiments across different 96-well plates. To normalize, values for the WT baseline measurements were averaged, and then all other values for treated WT samples and all KO samples were divided by that averaged value. In this way, WT untreated samples were approximately 1 across plates, and other values were a percentage of WT untreated samples. Normalized values were then combined for statistical analyses. For flow cytometry analysis of MitoSOX and MitoTracker Orange CMTMRos, cells were loaded with 5x10 À4 mg/mL or 3x10 À6 mg/mL of dye, respectively. After washings to remove dyes, cells were suspended in PBS + 0.1% BSA and analyzed on a BD Biosciences LSR II Cytometer. For these functional analyses performed on fibroblasts, cells were grown in low glucose DMEM, with supplements as describe above. Fibroblasts were seeded on gelatin-coated Seahorse assay plates at 3.5x10 4 /well 4 hr prior experimentation. For flow cytometry analyses, cells were grown to $80% confluency in a 24-well plate.
ATP measurements
To measure ATP production in age P9-10 mice, mitochondria were extracted as above and maintained on ice. After adjusting volumes to make equal protein concentrations, equal volumes of mitochondria were plated in duplicate in a 96-well plate and loaded into a GloMax-Multi+ Microplate Multimode Reader (Promega). A timed injection of respiration buffer (ME buffer with 1 mM malate, 1 mM pyruvate, 0.1 mM ADP) was followed by a 1 s delay, and then a luciferase injection (Roche, ATP CLS II kit), which allowed for determining ATP production over time. Luminescence was integrated for 1 s, every 10 s for 20 total readings ($3.5 min).
To measure ATP content in fibroblasts, 1.0x10 4 cells were plated in triplicate wells of 96-well white plates. After allowing 12 hours to re-establish homeostasis, cells were provided fresh media, incubated for 4 hr, and then analyzed by CellTiter-Glo 2.0 following the manufacturer's protocol. Duplicate plates were also made in clear 96-well plates to confirm cell adherence and subsequently measure protein concentration for standardization. A standard curve of ATP molar concentrations 10 À12 -10 À3 was used for all ATP experiments.
Mitochondrial morphometrics
Electron microscopic analysis of mitochondria was performed as above and previously described. Briefly, YFP-positive cortical PNs were immunolabeled with primary and secondary antibodies, and then visualized with glucose oxidase-DAB. Stained sections were further processed before ultrathin sectioning, placing in Formvar-coated single-slot grids, and analyzed with a Tecnai 12 Biotwin electron microscope (FEI). We analyzed five WT mice and six KO mice, aged 2 months, and five cells from each mouse. Measurements of mitochondria were performed using ImageJ.
Electrophysiology
We used 3-to 4-week -ld mice to perform electrophysiology similar to as previously described. Briefly, after mice were anaesthetized with isoflurane and decapitated, the brains were rapidly removed and immersed in cold (4 C) oxygenated high-sucrose solution containing (in mM): sucrose 220, KCl 2.5, NaH 2 PO 4 1.23, NaHCO 3 26, CaCl 2 1, MgCl 2 6, and glucose 10, pH (7.3) with NaOH. Coronal slices (300 mm thick) were cut on a vibratome and maintained in a holding chamber with artificial cerebrospinal fluid (ACSF, bubbled with 5% CO2 and 95% O2) containing (in mM): NaCl 124, KCl 3, CaCl 2 2, MgCl 2 2, NaH 2 PO 4 1.23, NaHCO 3 25, and glucose 2.5, (pH) 7.4 with NaOH. After a 1-hr recovery period, slices were transferred to a recording chamber and were constantly perfused with ACSF (33 C) at a rate of 2 mL/min. Both input resistance and series resistance were monitored throughout the experiments and keeping only those that were stable. Initial resting membrane potential measurements were done after a 10 min stabilization period from time of patching onto YFP-positive neurons. For these cells, the compounds tolbutamide (0.1 mM) or NaN 3 (1 mM) were applied in the bath perfusion in the appropriate experiments. At the end of the perforated patch recordings, the membrane of every cell was ruptured and whole-cell patch recording was measured to check current-voltage relationship. All data were analyzed with an Apple Macintosh computer using AxoGraph X.
Systemic physiology and metabolism
Glucose tolerance and insulin tolerance tests were performed as described previously by several publications. Briefly, baseline glucose levels were measured followed by an intraperitoneal injection of 20% glucose (10 mL/kg) or insulin (0.7 5U/kg), respectively. Glucose tolerance tested mice were fasted overnight. Blood glucose levels were measured at 15, 30, 60, and 120 min after injection. Five male mice of each genotype were used.
Metabolic cages were used as described previously by several publications. Briefly, seven WT mice and five KO male mice were individually housed and acclimated in metabolic chambers for seven days before 48 consecutive hours of measurements. Weights were recorded prior to acclimation. All gas exchange, diet, and locomotion measures were recorded for analysis by the metabolic chamber system.
Behavioral analysis
Mice between 2-4 months old were used for social interaction, open-field, active avoidance, and rotarod tests, essentially as described previously (Moy et al., 2007) . For the sociability tests, mice had one training day of 10 minutes with no stimuli in the 3-chambered apparatus, which had retractable doorways to separate the chambers. The next day, mice were given one, ten minute exploratory trial in the apparatus, followed by 10 minutes with stranger mouse 1, and then 10 min with stranger mice 1 and 2. For the open-field test, naive mice were placed in a black-walled, 37 3 37 3 37 cm box and monitored for 30 min. Times, distances, and areas were videoed and analyzed using ANY-maze software.
The Active avoidance test was based on previous studies. On day 0, mice were habituated to the chamber with an open door and no stimuli for 10 minutes. On day 1, mice were placed on the ''shock'' side for 10 s, after which the door was opened and tone was initiated (t = 0). At t = 10 s, a mild foot shock was initiated (0.15 mA) and sustained until the mouse crossed to the safe chamber, or until t = 30 s, at which point the shock was terminated and door closed. If the mouse crossed to the safe chamber before t = 30, it was given 10-30 s of rest and then placed on the shock side before starting the next trial after another 20-30 s. Day 1 consisted of six trials and days 2-7 consisted of fifteen trials each day.
For rotarod tests, mice were given three consecutive days of training on the apparatus, three trials each day, and were tested on the fourth day. The rotarod parameters were acceleration from 0 rpm to a maximum 40 rpm over 90 s.
iPS cell reprogramming and differentiation
Human iPSCs were generated by reprogramming of human skin fibroblasts with episomal vectors pCXLE-hOCT3.4-shp53-F, pCXLE-hSK, pCXLE-hUL, and pCXLE-EGFP obtained from Addgene. Human fibroblasts (2 x 10 6 ) collected from unaffected donors (n = 3) and patients affected with WS (n = 4) were nucleofected with 1.5 ug of each episome using Amaxa Nucleofector II and Amaxa NHDF nucleofector kit, and then seeded onto 100-mm dishes coated with 1:50 diluted growth factor reduced Matrigel. Cultures were grown under hypoxic conditions in Essential 6 medium supplemented with 100 ng/mL bFGF, hydrocortisone 100 nM, and sodium butyrate 0.5 mM. Cells were re-plated 10 days after transduction onto 100-mm dishes coated with Matrigel at 5000 cells/cm 2 density and cultured under hypoxic conditions in Essential 6 medium supplemented with 100 ng/mL bFGF. Colonies were selected for further expansion and evaluation 24-34 days after plating.
iPSC lines were cultured under hypoxic conditions in Essential 8 Flex medium on plates coated with Matrigel diluted 1:100 and were passaged using a 0.5 mM EDTA solution for long-term expansion. To validate iPSC lines, we used PCR to confirm electroporated plasmids were not integrated, karyotyping by Yale Cytogenetics Lab to confirm no chromosomal rearrangements had occurred, and teratoma assays by Yale Mouse Research Pathology Service and immunofluorescence of marker genes to confirm pluripotency. All measures were passed before a cell line was used for subsequent differentiation.
Human iPSCs directed differentiation into neocortical neurons was achieved by applying a monolayer, feeder-free, dual SMAD inhibition-based differentiation protocol (Okita et al., 2011; Onorati et al., 2016) . Briefly, iPSCs were dissociated to single cells through incubation with Accutase at 37 C, seeded at 0.7-2 3 10 5 cells/cm 2 density on plates coated with Matrigel diluted 1:50 and cultured in Essential 8 Flex medium supplemented with 10 mM ROCK inhibitor Y-27632. ROCK inhibitor was withdrawn the next day, and the iPSCs were allowed to expand in Essential 8 FLEX medium until the cells were nearly confluent. Neural differentiation was started by changing the culture medium to neural induction medium composed of a 1:1 mixture of DMEM/F-12 and Neurobasal supplemented with N-2, B-27, 20 mg/ml Insulin, 1% L-glutamine 200 mM, 1% MEM Non-Essential Amino Acids, 0.1 mM 2-mercaptoethanol, 100 nM LDN-193189, 10 mM SB-431542, and 2 mM XAV 939. Cells were cultured in neural induction medium for 11 days changing the medium daily. The efficiency of neural induction was monitored visually by assessing the appearance of cells with characteristic neuroepithelial morphology and the formation of neural rosettes. On day 12, neuroepithelial cells were harvested through incubation with Accutase at 37 C for approximately 15-20 minutes and replated onto on 13 mm glass coverslips or 6-well plates previously coated with 10 mg/mL Poly-D-lysine and 3 mg/mL Laminin at 0.7 cells/cm 2 density in neural induction medium supplemented with 100 nM LDN-193189 and 10 uM ROCK inhibitor. After replating, the medium was progressively switched through partial media changes to neural differentiation medium which contained Neurobasal supplemented with N-2, B-27, 1% Penicillin/Streptomycin, 1% GlutaMAX, and 30 ng/mL BDNF human recombinant protein. Cultures were maintained for up to 80 days of differentiation changing the medium partially every 2-3 days.
Histology
For the Golgi-Kopsch stain, we followed a protocol previously described (Chailangkarn et al., 2016) . Briefly, blocks $0.5-1.0cm 3 of cortex were incubated in 3.5% potassium dichromate, 15% sucrose, and 0.6% formaldehyde for 7 days, followed by incubation in 0.75% silver nitrate for 3 days, and finally dehydrated overnight in 95% ethanol. Blocks were then sectioned on a vibratome at 200mm, cleared in Histo-Clear, and mounted on microscope slides with Permount and coverslips. Silver impregnation was generally poor in STC areas of all brains. The best cells that appeared fully impregnated (several branched apical and basal dendrites from easily identifiable soma) were in the deep layers of M1C, and for this reason only these cells were analyzed. The impregnation was not sufficient to reliably quantify spines/dendritic protrusions.
For Nissl staining, 50 mm brain sections were mounted on microscope slides, and once dried, slides were rinsed in water. Slides were then immersed in 0.1% cresyl violet acetate at room temperature until most cells were fully penetrated ($30 min). Slides were rinsed in 70% ethanol, then 90% ethanol, 2x 100% ethanol, and finally xylenes before covering with a coverslip and Permount mounting media. Soma area was counted by first identifying the layer within the region of interest and tracing pyramidal-shaped cells with Neurolucida software. Motor cortex layer 5B was identified by the presence of Betz cells, however these cells were not measured because a disproportionate number of cells of such large size could easily skew data. Also, soma area greater or less than two standard deviations from average were removed before final statistical analysis. Cell density was performed using ImageJ to place standardized grids over low magnification images of Nissl-stained sections. Two non-adjacent grids were used to count pyramidal-shaped cells and the average of the two grids were used to represent the density for that layer and cortical area.
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistics were performed using Microsoft Excel and GraphPad Prism software. Where only two groups were compared, a two-tailed Student's t test was used. The exception was in the electrophysiology studies where a one-tailed t test was used because values were expected to move in only one direction of the mean following drug treatment. Where there were three or more groups compared, one-way ANOVA followed by Dunnett's multiple comparisons test was used, and repeated-measure ANOVA was used for the active avoidance test. For the corpus callosum and axon distribution measurements, and for behavior tests, multiple t tests were performed and significance determined using the Holm-Sidak method. p < 0.05 was considered significant for all studies. Figures were organized with Adobe Illustrator and Adobe Photoshop.
DATA AND SOFTWARE AVAILABILITY
We generated custom scripts to identify or provide information listed below. All scripts will be made available to investigators who request them. The scripts are: (1) Pearson correlation coefficient for exon-array-generated brain transcriptome, (2) Pearson correlation coefficient for RNA-seq-generated brain transcriptome, (3) co-expression cluster analysis, (4) co-expression significance analysis using proteinprotein interaction network, (5) tissue specificity analysis across multiple tissues using GTEx RNaseq data, (6) co-expression cluster significance against null expectation, (7) tissue specificity across spatio-time interval (BrainSpan RNaseq data) with 7q11.23 CNV genes, (8) tissue specificity across spatio-time interval (BrainSpan RNaseq data) with 7q11.23 CNV genes + network neighbors. Figure S1 . Clusters 1 and 2 Exhibit Spatio-temporal Brain-Enriched Expression, Related to Figure 1 
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